The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis

被引:40
作者
Gao, Fei [1 ]
Zhou, Bin [2 ]
Xu, Jun-Chi [3 ]
Gao, Xin [1 ]
Li, Shu-Xiang [1 ]
Zhu, Geng-Chao [1 ]
Zhang, Xue Guang [2 ]
Yang, Chen [1 ]
机构
[1] Nanjing Med Univ, Affiliated Suzhou Hosp, Suzhou 215000, Jiangsu, Peoples R China
[2] Soochow Univ, Inst Clin Immunol Jiangsu Prov, Suzhou 215007, Peoples R China
[3] Fifth Peoples Hosp Suzhou, Suzhou, Jiangsu, Peoples R China
关键词
LGR5; ALDH1A1; NSCLC; Clinical pathology; Prognosis; STEM-CELLS; EXPRESSION; IDENTIFICATION; PROMISE; MARKER; COLON;
D O I
10.1016/j.bbrc.2015.04.029
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Leucine rich repeat containing G protein coupled receptor 5 (LGR5), may be a candidate marker of non-small cell lung cancer (NSCLC) cells with stem cell-like properties. Aldehyde dehydrogenase 1A1 (ALDH1A1) is one of NSCLC stem cell markers. To identify the relationship of LGR5 and ALDH1A1 in NSCLC, we analyzed the expression of LGR5 and ALDH1A1 in NSCLC samples, and determined their clinical significance. We performed quantitative RT-PCR for LGR5 and ALDH1A1 expression in 24 NSCLC patients, and showed that LGR5 and ALDH1A1 mRNA were frequently increased in NSCLC tissues in comparison to that in adjacent normal tissues (p = 0.0005 and p < 0.0001, respectively). Besides, the expression of LGR5 and ALDH1A1 mRNA has a significant correlation (r = 0.416, P = 0.0483). The expression of LGR5 and ALDH1A1 in 109 NSCLC tumors and 50 adjacent normal tissues were detected by immunohistochemistry. Positive LGR5 and ALDH1A1 expression was defined in 28.4% and 41.3% of the NSCLC tumors, respectively. Further analysis indicated that 24 of these LGR5(+) (24/31) samples expressed ALDH1A1(r = 0.3883, p < 0.0001), we also found co-localization of LGR5 and ALDH1A1 in tumor tissue samples. LGR5 and ALDH1A1 expression was significantly associated with higher pathological TNM stage of the disease (stage I + II and III + IV) (P = 0.0311 and p = 0.0221, respectively), the co-expression of LGR5 and ALDH1A1 was associated with nodal status (p = 0.0424). High expression of LGR5 or ALDH1A1 was related to poor prognosis (P = 0.0125 and p = 0.0410, respectively), and NSCLC patients with co-expression of LGR5 and ALDH1A1 had a poorer prognosis than the others (P = 0.0011). Both of them can be an independent risk factor of a poorer prognosis (P = 0.016 and P = 0.024, respectively). The expression of LGR5 and ALDH1A1 were closely associated with the tumorigenicity, metastasis and poor prognosis of NSCLC, and LGR5+ cells in NSCLC were likely to be the cancer cells with stem cell-like properties due to the significant correlation between LGR5 and ALDH1A1. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:91 / 98
页数:8
相关论文
共 21 条
  • [1] The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer
    Alamgeer, Muhammad
    Ganju, Vinod
    Szczepny, Anette
    Russell, Prudence A.
    Prodanovic, Zdenka
    Kumar, Beena
    Wainer, Zoe
    Brown, Tracey
    Schneider-Kolsky, Michal
    Conron, Matthew
    Wright, Gavin
    Watkins, D. Neil
    [J]. THORAX, 2013, 68 (12) : 1095 - 1104
  • [2] [Anonymous], INT J PROTEOMICS
  • [3] Identification of stem cells in small intestine and colon by marker gene Lgr5
    Barker, Nick
    van Es, Johan H.
    Kuipers, Jeroen
    Kujala, Pekka
    van den Born, Maaike
    Cozijnsen, Miranda
    Haegebarth, Andrea
    Korving, Jeroen
    Begthel, Harry
    Peters, Peter J.
    Clevers, Hans
    [J]. NATURE, 2007, 449 (7165) : 1003 - U1
  • [4] Crypt stem cells as the cells-of-origin of intestinal cancer
    Barker, Nick
    Ridgway, Rachel A.
    van Es, Johan H.
    van de Wetering, Marc
    Begthel, Harry
    van den Born, Maaike
    Danenberg, Esther
    Clarke, Alan R.
    Sansom, Owen J.
    Clevers, Hans
    [J]. NATURE, 2009, 457 (7229) : 608 - U119
  • [5] Steroid Receptor Coactivator-3 Expression in Lung Cancer and Its Role in the Regulation of Cancer Cell Survival and Proliferation
    Cai, Di
    Shames, David S.
    Raso, Maria Gabriela
    Xie, Yang
    Kim, Young H.
    Pollack, Jonathan R.
    Girard, Luc
    Sullivan, James P.
    Gao, Boning
    Peyton, Michael
    Nanjundan, Meera
    Byers, Lauren
    Heymach, John
    Mills, Gordon
    Gazdar, Adi F.
    Wistuba, Ignacio
    Kodadek, Thomas
    Minna, John D.
    [J]. CANCER RESEARCH, 2010, 70 (16) : 6477 - 6485
  • [6] The therapeutic promise of the cancer stem cell concept
    Frank, Natasha Y.
    Schatton, Tobias
    Frank, Markus H.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (01) : 41 - 50
  • [7] Lung cancer and lung stem cells - Strange bedfellows?
    Giangreco, Adam
    Groot, Karen R.
    Janes, Sam M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 175 (06) : 547 - 553
  • [8] Molecular origins of cancer: Lung cancer
    Herbst, Roy S.
    Heymach, John V.
    Lippman, Scott M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (13) : 1367 - 1380
  • [9] Cancer statistics, 2007
    Jemal, Ahmedin
    Siegel, Rebecca
    Ward, Elizabeth
    Murray, Taylor
    Xu, Jiaquan
    Thun, Michael J.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2007, 57 (01) : 43 - 66
  • [10] Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer
    Jiang, Feng
    Qiu, Qi
    Khanna, Abha
    Todd, Nevins W.
    Deepak, Janaki
    Xing, Lingxiao
    Wang, Huijun
    Liu, Zhenqiu
    Su, Yun
    Stass, Sanford A.
    Katz, Ruth L.
    [J]. MOLECULAR CANCER RESEARCH, 2009, 7 (03) : 330 - 338